| 产品详情 |
| Edit |   |
|---|
| Product Name | Osteoprotegerin, Recombinant, Human |
|---|
| Description | Purity ~98% (SDS-PAGE and HPLC). Endotoxin: ≤0.1ng/ug. Human OPG (Osteoprotegerin), also known as OCIF (Osteoclastogenesis inhibitory factor), is a member of the TNF receptor superfamily. Recombinant human OPG/OCIF specifically acts on bone tissues and increases bone mineral density and bone volume associated with a decrease of active osteoclast number. Recombinant human OPG is a 20kD protein, comprising of 174 amino acid residues. Recombinant Human Osteoprotegerin (OPG) expressed in E. coli. Biological Activity: Determined by its ability to neutralize the stimulation of U937 cells treated with 10ng/ml of sRANKL. |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Osteoprotegerin, Recombinant, Human (OPG, MGC29565, Osteoclastogenesis Inhibitory Factor, OCIF, TR1, Tumor Necrosis Factor Receptor Superfamily Member 11B, TNFRSF11B) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | O8065-01H |
|---|
| Price | |
|---|
| Order / More Info | Osteoprotegerin, Recombinant, Human from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|